985 related articles for article (PubMed ID: 28429473)
1. Surgery for limited-stage small-cell lung cancer.
Barnes H; See K; Barnett S; Manser R
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011917. PubMed ID: 28429473
[TBL] [Abstract][Full Text] [Related]
2. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.
Amarasena IU; Chatterjee S; Walters JA; Wood-Baker R; Fong KM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD006849. PubMed ID: 26233609
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Burdett S; Pignon JP; Tierney J; Tribodet H; Stewart L; Le Pechoux C; Aupérin A; Le Chevalier T; Stephens RJ; Arriagada R; Higgins JP; Johnson DH; Van Meerbeeck J; Parmar MK; Souhami RL; Bergman B; Douillard JY; Dunant A; Endo C; Girling D; Kato H; Keller SM; Kimura H; Knuuttila A; Kodama K; Komaki R; Kris MG; Lad T; Mineo T; Piantadosi S; Rosell R; Scagliotti G; Seymour LK; Shepherd FA; Sylvester R; Tada H; Tanaka F; Torri V; Waller D; Liang Y;
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD011430. PubMed ID: 25730344
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743
[TBL] [Abstract][Full Text] [Related]
6. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.
Amarasena IU; Walters JA; Wood-Baker R; Fong K
Cochrane Database Syst Rev; 2008 Oct; (4):CD006849. PubMed ID: 18843733
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy versus best supportive care for extensive small cell lung cancer.
Pelayo Alvarez M; Westeel V; Cortés-Jofré M; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Nov; (11):CD001990. PubMed ID: 24282143
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Falcetta FS; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT; Rosa DD
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD005342. PubMed ID: 27873308
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Rosa DD; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT
Cochrane Database Syst Rev; 2012 Jun; 6(6):CD005342. PubMed ID: 22696349
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for brain metastases from small cell lung cancer.
Reveiz L; Rueda JR; Cardona AF
Cochrane Database Syst Rev; 2012 Jun; (6):CD007464. PubMed ID: 22696370
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
13. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
15. Radical multimodality therapy for malignant pleural mesothelioma.
Abdel-Rahman O; Elsayed Z; Mohamed H; Eltobgy M
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012605. PubMed ID: 29309720
[TBL] [Abstract][Full Text] [Related]
16. Surgery for early stage non-small cell lung cancer.
Manser R; Wright G; Hart D; Byrnes G; Campbell DA
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD004699. PubMed ID: 15674959
[TBL] [Abstract][Full Text] [Related]
17. A systematic overview of chemotherapy effects in non-small cell lung cancer.
Sörenson S; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939
[TBL] [Abstract][Full Text] [Related]
18. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.
Thomas DC; Arnold BN; Rosen JE; Salazar MC; Blasberg JD; Detterbeck FC; Boffa DJ; Kim AW
Lung Cancer; 2017 Jan; 103():75-81. PubMed ID: 28024700
[TBL] [Abstract][Full Text] [Related]
19. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
20. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]